Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from Cogstate Ltd ( (AU:CGS) ).
Cogstate Ltd announced that it will release its financial results for the first half of the fiscal year 2025 on February 20, 2025. The company will also host a live webcast and Q&A session on the same day, providing stakeholders with an opportunity to engage directly with the executive team. This announcement serves to keep investors informed and engaged, reflecting Cogstate’s commitment to transparency and its proactive approach to stakeholder communication.
More about Cogstate Ltd
Cogstate Ltd is a neuroscience technology company that focuses on optimizing brain health assessments to advance medicine development and provide earlier clinical insights in healthcare. The company offers computerized cognitive tests, electronic clinical outcome assessment solutions, and quality assurance services for clinical trial endpoints. Cogstate has partnered with pharmaceutical company Eisai to distribute its assessments in the USA and Asia.
YTD Price Performance: 10.74%
Average Trading Volume: 9,974
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $129.4M
For a thorough assessment of CGS stock, go to TipRanks’ Stock Analysis page.
